Skip to content
The Policy VaultThe Policy Vault

Ztalmy (ganaxolone) oral suspension — Point32Health

seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD)

Initial criteria

  • Diagnosis of cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) AND patient age ≥ 2 years AND prescribed by or in consultation with a neurologist